Axiom Bio
PrivateTotal Funding Raised
$15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Axiom Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. It has raised $15M.
Axiom Bio is a biotechnology company that provides AI-driven predictive models to assess molecular toxicity in drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axiom Bio Comparables
Compare Axiom Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 83% | |
| VeriSIM Life | 81% | |
| PredictCan Biotechnologies | 81% |
For institutional investors. Book with your work email.
Axiom Bio Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axiom Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zetta Venture Partners | Seed |
| Amplify Partners | Seed |
| Dimension | Seed |
| Dimension Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 56% MoM.
- Jul 11, 2026
7 of the top 20 pharmaceutical companies are using their system.
For institutional investors. Book with your work email.
Axiom Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axiom Bio's valuation, stock price, and market status.
Is Axiom Bio a public or private company?
Axiom Bio is a private company.
What is the current stock price of Axiom Bio?
Axiom Bio is a private company, so its shares have no public market price. Caplight tracks Axiom Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axiom Bio worth (valuation)?
Valuation information for Axiom Bio is not publicly available.
Can I buy Axiom Bio stock?
Axiom Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axiom Bio's last funding round?
Funding round information for Axiom Bio is not publicly available.
Who are the main investors in Axiom Bio?
Key investors in Axiom Bio include Amplify Partners.
Will Axiom Bio IPO soon?
No public IPO plans have been announced for Axiom Bio.
How can I track Axiom Bio secondary market activity?
Caplight tracks bids, offers, and trades in Axiom Bio's shares on secondary markets.